Generics
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamin...
Prasco increases Ohio pharmaceutical footprint
1 September 2026 - Prasco LLC, a pharmaceutical commercialisation company specialising in authorised generics, today announced on Monday the acquisition of a strategically located distribution facilit...
Upsher-Smith launches Glatiramer Acetate Injection generic
21 August 2026 - Upsher-Smith Laboratories LLC, a US subsidiary of Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY), announced on Thursday the launch of Glatiramer Acetate Injection in 20 mg/mL and...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed Internatio...
Henlius and Sandoz expand biosimilars collaboration
17 August 2026 - Shanghai-based biopharmaceutical company Shanghai Henlius Biotech, Inc. (HKG: 2696) said on Monday it has agreed a strategic collaboration with generic biosimilars company Sandoz Grou...
Aurisco Pharmaceutical reports successful US FDA inspection
13 August 2026 - Oligonucleotide and peptide (TIDES) manufacturer Aurisco Pharmaceutical Co Ltd (SSE:605116) announced on Wednesday that its site in Yangzhou, China has passed US FDA inspection as the...